| Anesthetic management for ascending aorta replacement in a patient who refused autologous transfusion for religious reasons. | |
| | |
MedLine Citation:
|
PMID: 19685130 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We report on the anesthetic management of a 69-year-old female Jehovah's Witness undergoing cardiopulmonary bypass to replace the ascending aorta; the patient refused transfusion of stored autologous or allogeneic blood products for religious reasons. The strategy involved preoperative hematopoiesis with recombinant human erythropoietin and iron, intraoperative acute normovolemic hemodilution, the use of a cell-saver system, administration of high-dose tranexamic acid, controlled hypotension, avoidance of low body temperature, simplification of the surgery, and lower blood dilution during cardiopulmonary bypass. |
| | |
Authors:
|
Shinju Obara; Masayuki Nakagawa; Shinichiro Takahashi; Masahiko Akatu; Tsuyoshi Isosu; Masahiro Murakawa |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2009-08-14 |
Journal Detail:
|
Title: Journal of anesthesia Volume: 23 ISSN: 1438-8359 ISO Abbreviation: J Anesth Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-08-17 Completed Date: 2009-12-07 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8905667 Medline TA: J Anesth Country: Japan |
Other Details:
|
Languages: eng Pagination: 436-8 Citation Subset: IM |
Affiliation:
|
Department of Anesthesiology, Fukushima Medical University School of Medicine, 1 Hikari-gaoka, Fukushima 960-1295, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Anesthesia, General Angioplasty Anticoagulants / therapeutic use Antifibrinolytic Agents / therapeutic use Aorta / surgery* Blood Transfusion, Autologous* Blood Volume Cardiopulmonary Bypass Erythropoietin, Recombinant / therapeutic use Female Hematopoiesis / drug effects Hemodilution Heparin / therapeutic use Humans Hypotension, Controlled Jehovah's Witnesses* Tranexamic Acid / therapeutic use Treatment Refusal |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Antifibrinolytic Agents; 0/Erythropoietin, Recombinant; 1197-18-8/Tranexamic Acid; 9005-49-6/Heparin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Esophageal tear in a patient undergoing stereotactic brain biopsy under general anesthesia.
Next Document: Atracurium during induced hyperthermia.